Tobias Gessler
Giessen, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Association of Patients' Knowledge on the Disease and Its Management with Indicators of Disease Severity and Individual Characteristics in Patients with Chronic Obstructive Pulmonary Disease (COPD): Results from COSYCONET 2.
Journal: Patient preference and adherence
Published: July 22, 2024
Search for Axionlike Particles Produced in e^{+}e^{-} Collisions at Belle II.
Journal: Physical review letters
Published: July 26, 2020
Search for an Invisibly Decaying Z^{'} Boson at Belle II in e^{+}e^{-}→μ^{+}μ^{-}(e^{±}μ^{∓}) Plus Missing Energy Final States.
Journal: Physical review letters
Published: December 24, 2019
lloprost delivered via the BREELIBTM nebulizer: a review of the clinical evidence for efficacy and safety.
Journal: Therapeutic advances in respiratory disease
Published: March 16, 2019
Inhalation of repurposed drugs to treat pulmonary hypertension.
Journal: Advanced drug delivery reviews
Published: March 07, 2018
The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension.
Journal: Pulmonary circulation
Published: June 10, 2017
Potential of the isolated lung technique for the examination of sildenafil absorption from lung-delivered poly(lactide-co-glycolide) microparticles.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 18, 2015
Innovative formulations for controlled drug delivery to the lungs and the technical and toxicological challenges to overcome(.).
Journal: Current pharmaceutical design
Published: November 05, 2015
Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: June 20, 2015
Systematic aging of degradable nanosuspension ameliorates vibrating-mesh nebulizer performance.
Journal: Drug development and industrial pharmacy
Published: December 19, 2014
Characterization of lung-delivered in-situ forming controlled release formulations.
Journal: The Journal of pharmacy and pharmacology
Published: December 10, 2014
Inhaled granulocyte/macrophage colony-stimulating factor as treatment of pneumonia-associated acute respiratory distress syndrome.
Journal: American journal of respiratory and critical care medicine
Published: March 04, 2014
Last Updated: 09/26/2026